Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause Diffuse large b-cell lymphoma? 13 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Diffuse large b-cell lymphoma have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.0% of all adverse event reports for LEFLUNOMIDE.

13
Reports of Diffuse large b-cell lymphoma with LEFLUNOMIDE
0.0%
of all LEFLUNOMIDE reports
2
Deaths
4
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From LEFLUNOMIDE?

Of the 13 reports, 2 (15.4%) resulted in death, 4 (30.8%) required hospitalization, and 3 (23.1%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which LEFLUNOMIDE Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma LEFLUNOMIDE Demographics